A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)

Last updated: March 27, 2025
Sponsor: Mind Medicine, Inc.
Overall Status: Active - Recruiting

Phase

3

Condition

Anxiety Disorders

Panic Disorders

Mood Disorders

Treatment

Placebo

MM120 (LSD D-Tartrate)

Clinical Study ID

NCT06809595
MM120-301
  • Ages 18-74
  • All Genders

Study Summary

A Phase 3, Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating MM120 Compared to Placebo in Generalized Anxiety Disorder - Panorama

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Diagnosis of GAD per DSM-5

  2. Male or female aged 18 to 74

  3. HAM-A Total Score ≥20

Exclusion

Exclusion Criteria:

  1. Certain psychiatric disorders (other than generalized anxiety disorder)

  2. First degree relative with or lifetime history of a psychotic disorder or bipolardisorder

  3. Current diagnosis of alcohol or substance use disorder (excluding nicotine andcaffeine)

  4. Any clinically significant unstable illness

Study Design

Total Participants: 250
Treatment Group(s): 2
Primary Treatment: Placebo
Phase: 3
Study Start date:
January 29, 2025
Estimated Completion Date:
May 31, 2027

Study Description

The study will enroll up to 375 participants aged 18 to 74 years, inclusive with a Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) confirmed primary diagnosis of GAD and a minimum HAM A total score of at least 20 at Screening and Baseline without clinically relevant medical or psychiatric history.

The study consists of a 12-week randomized, double-blind, single-dose administration period evaluating MM120 versus placebo, followed by a 40-week extension phase with the opportunity for open-label treatment. During this phase, participants will be monitored and evaluated for potential treatment with MM120 based on pre-specified safety and symptom severity criteria.

Connect with a study center

  • Preferred Research Partners, Inc.

    Little Rock, Arkansas 72211
    United States

    Active - Recruiting

  • West Los Angeles VA Medical Center

    Los Angeles, California 90073
    United States

    Site Not Available

  • Cenexel-CNS

    Torrance, California 90504
    United States

    Active - Recruiting

  • Bradenton Research Center, Inc.

    Bradenton, Florida 34205
    United States

    Active - Recruiting

  • Clinical Neuroscience Solutions, Inc

    Orlando, Florida 32801
    United States

    Active - Recruiting

  • Atlanta Center for Medical Research

    Atlanta, Georgia 30331
    United States

    Active - Recruiting

  • Sheppard Pratt Health System

    Towson, Maryland 21204
    United States

    Site Not Available

  • Copley Clinical

    Boston, Massachusetts 02116
    United States

    Active - Recruiting

  • Princeton Medical Institute

    Princeton, New Jersey 08540
    United States

    Active - Recruiting

  • University of Cincinnati Psychiatry- Anxiety Disorders Research Program

    Cincinnati, Ohio 45219
    United States

    Site Not Available

  • Neuro-Behavioral Clinical Research, Inc.

    North Canton, Ohio 44720
    United States

    Active - Recruiting

  • Austin Clinical Trial Partners

    Austin, Texas 78737
    United States

    Active - Recruiting

  • Cedar Clinical Research

    Murray, Utah 84107
    United States

    Active - Recruiting

  • Core Clinical Research

    Everett, Washington 98201
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.